Australian Business GrantsFinder
Ongoing

R&D Tax Incentive - Clinical Trials

Funding
Varies
Region
Australia
View Official Page

Overview

A tax incentive program that deems clinical trial activities as core R&D activities eligible for the R&D Tax Incentive. Companies conducting clinical trials registered with the TGA can claim tax benefits for their R&D activities related to these trials.

Eligibility Requirements

Clinical trials must be registered with the TGA (Therapeutic Goods Administration) and have a valid CTA (Clinical Trial Authorisation) or CTN (Clinical Trial Notification) number. All parts of the core R&D activity must occur solely in Australia to be eligible.

Who Can Apply

SmeStartups

Relevant Industries

Health

How to Apply

Applications are submitted through the official government portal. Review the eligibility criteria carefully before applying, and ensure all supporting documents are prepared.

Visit the official application page
Disclaimer: Grant information is sourced from official government websites and updated regularly. Always verify current eligibility and deadlines on the official program page before applying.

Related Grants

Ongoing·Commonwealth·$800,000 - $19,200,000

Blood Borne Viruses (BBV) and Sexually Transmissible Infections (STI) Research Program

This grant program is delivered, in part, through the collection of data, ongoing surveillance, and pertinent research and evaluation activities related to the BBV and STI outlined in the National BBV and STI Strategies, namely: National Hepatitis B Strategy National Hepatitis C Strategy National STI Strategy National Aboriginal and Torres Strait Islander BBV and STI Strategy National HIV Strategy. The Department’s First National BBV and STI Research Strategy 2021-2025 and its future iterations (the National BBV and STI Research Strategy), sets out the aims and objectives for the multi-disciplinary research activities undertaken within Australia and supports the implementation of the related National BBV and STI Strategies. By enabling and focussing on the conduct of BBV and STI research, the Research Strategy aims to identify challenges, barriers and opportunities to achieve the agreed national goals and targets of the National BBV and STI Strategies. The Research Strategy also contai

Open·Commonwealth

Closing the Gap Outcomes and Evidence Fund – Logan Service Delivery Agreement

A program inviting First Nations people, organisations and communities to co-design, trial and evaluate projects aimed at contributing to Closing the Gap Targets 12 (out-of-home care) and 13 (family violence). The Fund supports trial projects with evaluation to improve the evidence base for the Australian Government and First Nations people, with projects running until 30 June 2026.

Open·Commonwealth·Up to $76,269,844

National Palliative Care Projects

The National Palliative Care Projects represent a long-standing commitment by the Australian Government to improve the quality, accessibility, and coordination of palliative care services across the country. These projects have supported national leadership, innovation, and capacity-building in palliative care through investments in research, education, workforce development, and community engagement. To view the grant opportunity documents, please select the red "Grant Opportunity Documents" button on the left-hand side. Eligibility: To be eligible you must be one of the following entity types. • Indigenous Corporation (registered under the Corporations (Aboriginal and /or Torres Strait Islander) Act 2006) • Company • Corporate Commonwealth Entity • Non-Corporate Commonwealth Statutory Authority • Corporate State or Territory Entity • Non-corporate State or Territory Entity • Non-corporate State or Territory Statutory Authority • Local Government • Cooperative • Incorporated Associati